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INTRODUCTION
Radical hysterectomy with pelvic lymphadenectomy is con-
sidered the standard surgical treatment for early stage cervical
cancer. The term radical hysterectomy has been widely used to
define operations with striking variation in radicality among
surgeons. It is known that the risk of skip metastasis to the
para-aortic area is negligible in early stage cervical cancer (1).
The proper indications for radical hysterectomy and the role
of extreme radicality in effectiveness of cure in patients with
cervical cancer still remain debatable, and attempts have been
made to identify a subset of pa-tients with early stage cervi-
cal cancer eligible for less extensive radical surgery (2). The
sentinel lymph node is defined as the first node of a regional
lymphatic basin that receives the lymphatic drainage from a
tumor (3), thus representing an elective site of lymph node
metastasis (4). According to the sentinel lymph node hypoth-
esis, histologically negative sentinel lymph nodes can guar-
antee the histological negativity of the remaining regional
lymph nodes (5). It has been demonstrated that there is an
orderly and predictable pattern of lymphatic flow in cervical
cancers, and there is a sequential progression of tumor cells
passing by means of lymphatic vessels to the primary draining
lymph node; the first lymph node filters the afferent lymph,
whereby the tumor cells become entrapped. The evolution of
the tumor cells is influenced by the immunologic response
generated within the lymph node. These assumptions suggest
that the sentinel node can be a suitable marker of regional
lymph node status. Thus sentinel node biopsy may be a rea-
sonable alternative to unnecessary pelvic lymph nodes dissec-
tion and a suitable method for limited control of early stage
cervical cancer. To improve the sentinel node detection in
surgical procedures, we investigated lymphatic mapping of
sentinel lymph nodes with isosulfan blue dye (lymphazur 1%)
and technetium-99m colloid albumin. The sentinel lymph
node frozen biopsy for early stage cervical cancer is gaining a
widespread interest due to its accurate prediction of the re-
gional lymph node status (95-100%) that could safely avoid
extensive dissection of the regional lymph nodes. 
The concept of the sentinel lymph node was introduced by
Cabanas in 1977 with regard to the management of penile
carcinoma (6). He proposed that the lymph nodes that first
receive lymphatic drainage from a tumor could be removed
by limited surgery and examined to determine whether more
extensive lymph node dissection should be performed (7). The
technique of intraoperative lymphatic mapping for early stage
melanoma was described by Morton and others and has been
freely adapted to the cervical cancer with different routes of
injection, such as intradermal, subdermal, intraparenchymal,
or intratumoral, for marking the sentinel nodes (7-9). 
This study was aimed to evaluate the feasibility of lymphat-
ic mapping with a combined approach -isosulfan blue dye
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Sentinel Node Biopsy as an Indicator for Pelvic Nodes Dissection in
Early Stage Cervical Cancer
The purpose of this study was to investigate the feasibility of sentinel node frozen
biopsy to minimize the extensive pelvic lymph nodes dissection in early stage
cervical cancer patients on the basis that the risk of skip metastasis to the para-
aortic area is negligible. Twenty-six patients with early stage cervical cancer
were enrolled in this study. Technetium-99m colloid albumin (Tc
99m) was injected
intradermally around the tumor for allowing preoperative lymphoscintigraphy and
intraoperative hand-held gama probe detection of seninel nodes. For visual detec-
tion, isosulfan blue dye was injected into the peritumoral sites before peritoneal
opening. Postoperative morbidity and negative predictive value were the endpoints
of this study. The 26 patients, ranging in age from 32 to 71 yr, underwent intra-
operative sentinel nodes mapping. All the patients underwent complete pelvic
lymph nodes dissection including para-aortic nodes. There was one case with
positive non-sentinel nodes despite the negative sentinel node by frozen biopsy
(negative predictive value, 95.2%). This new technique of sentinel node map-
ping is safe and simple to perform. Further clinical trials using the combination of
Tc
99m and isosulfan blue dye are warranted and this technique will make a true
advance for less aggressive management of patients with early stage cervical
cancer. 
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and technetium 99m colloid albumin- and the correlation
between the sentinel node and non-sentinel nodes status and
their statistical significance in early stage cervical cancer.
MATERIALS AND METHODS
Patients selection
Between April 2001 and January 2002, 26 patients with
early stage cervical cancer successfully underwent sentinel
lymph node frozen biopsy. Lymphoscintigraphy was per-
formed in 24 of 26 cases and 2 of 26 cases received only iso-
sulfan blue dye injection during this period. Informed con-
sents about lymphatic mapping and sentinel lymph node
biopsy were obtained before surgical procedures. We per-
formed a prospective study on 26 consecutive patients un-
dergoing sentinel node frozen biopsy by isosulfan blue dye
and technetium-99m colloid albumin. In all patients, the
sentinel lymph node frozen biopsies were followed by exten-
sive pelvic lymph nodes dissection, regardless of the sentinel
lymph nodes status.
The lymphatic system of uterine cervix
There are two sets of lymphatic systems in the uterus (10,
11). One is the superficial lymphatic system and the other
is the deep one. The superficial lymphatic system is placed
beneath the peritoneum, and the deep one in the parenchyme
of the organ. The lymphatic vessels of the uterine cervix run
in three directions: transversely to the external iliac glands,
postero-laterally to the hypogastric glands, and posteriorly
to the common iliac glands. The majority of the vessels of
the body and fundus of the uterus pass lateralward through
the broad ligaments, and continue up with the ovarian ves-
sels to the lateral and para-aortic glands. A few, however, run
to the external iliac glands, and one or two run to the super-
ficial inguinal glands.
Lymphoscintigraphy and isosulfan blue dye administra-
tion 
Technetium-99m colloid albumin was used for lymphatic
mapping. The procedure was as follows; about 3 hr before
surgery, the patients were transported to the nuclear medicine
unit and subjected to large field scintillation camera-guided
peritumoral injection of 10-20 MBq technetium-99m colloid
albumin at 2 or 3 sites around the primary tumor (Fig. 1).
Dynamic scintigraphy was commenced immediately using a
large field scintillation camera. Static scintigraphy was pro-
longed for 20 to 40 min based on the visualization of sentinel
lymph node (Fig. 2). The scintigraphic hot spots in vivo were
detected using a hand-held gamma probe (Neoprobe 1500
�
Neoprobe Corp, Dublin, OH, U.S.A.). About 3 hr after tracer
injection, the patients were sent to the operation room and
radical hysterectomy with pelvic lymphadenectomy was per-
formed following sentinel lymph node frozen biopsy. After
induction of general anesthesia, isosulfan blue dye was inject-
ed in the peritumoral area with a 20-gauge needle (Fig. 3).
The sentinel lymph node identification was always followed
Fig. 1. Intradermal technetium-99m colloid albumin injection in an
early stage cervical cancer.
Fig. 2. Lymphoscintigraphy using a scintillation camera (arrow
indicates scintigraphic hot spot and shows the location of lymph
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by radical hysterectomy. The probe was used before making
the abdominal skin incision to identify the area of greatest
activity. Background activity was obtained in four areas of
abdomen. Usually, sentinel lymph nodes had 6-to 8- fold
radioactivity compared to non-sentinel lymph nodes as the
background. Careful dissection was performed to identify
the blue stained afferent lymphatic vessels, and they were
followed up to the first blue-stained lymph node. The hand-
held gamma probe was used to confirm the location of the
sentinel lymph nodes, as well as to guide the dissection when-
ever the afferent lymphatic channels were not detectable
(Fig. 4).
Removal of sentinel nodes and pathologic examination
The sentinel node was excised together with a rim of sur-
rounding tissue and sent as a separate specimen for intra-
operative histologic examination. A pathologist examined
all the surgically removed sentinel node specimens using a
standard technique. The nodes were isolated fresh from the
fat tissue. One section was taken per 5 mm of the greatest dimen-
sion. Nodes greater than 5 mm in diameter were divided into
two parts along the longitudinal axis. Nodes less than 5 mm
in the major axis were totally embedded. Three histological
sections were obtained from each specimen at different cut
levels and were stained with hematoxylin and eosin.
RESULTS
The 26 patients who underwent radical hysterectomy with
pelvic lymph nodes dissection using preoperative technetium-
99m colloid albumin and intraoperative isosulfan blue dye
injection were analyzed for the location of sentinel lymph
nodes and for the sensitivity and negative predictive value
for the purpose of clinical application of only sentinel lymph
node frozen biopsy for less extensive pelvic lymph nodes dis-
section in early stage cervical cancer. The order of sentinel
Fig. 3. Peritumoral injection of isosulfan blue dye around the cer-
vical lesion.
Fig. 4. Detection of sentinel lymph node using an isosulfan blue
dye and hand-held gamma probe (A: hand-held gamma probe.
Arrow indicates the sentinel lymph node).
A
External iliac 18
Obturator 12
Internal iliac 8
Parametrium 8
Common iliac 2
Inguinal 1
Locations of sentinel lymph node Number of detected 
sentinel lymph node
Table 1. Distribution of locations of sentinel lymph node in 26
cervical cancer patients
Frozen biopsy (-)* 20 cases 1 case 21 cases
Frozen biopsy (+)
� 1 case 4 cases 5 cases
Total 21 cases 5 cases 26 cases
Permanent 
pathology (-)
�
Permanent
pathology (+)
� Total
Table 2. Relationship between frozen biopsy of sentinel lymph
node and permanent pathology of pelvic lymph node
Frozen biopsy (-)* denotes the benign sentinel lymph node. Frozen biop-
sy (+)
�signifies the nodal status is malignant. 
� means there was no meta-
static lesion in pelvic lymph nodes and 
�implies there were metastatic
nodes in pelvic cavity.510 C.-C. Rhim, J.-S. Park, S.-N. Bae, et al.
node detection sites were external iliac, obturator, and inter-
nal iliac areas (Table 1). The location of the primary cancer
lesion had an influence on the detection sites of sentinel lymph
nodes. The average number of sentinel lymph nodes per pa-
tient was two. Among 21 cases where sentinel lymph nodes
were negative, pelvic lymph nodes were all negative except
for in one case. Among 5 cases where sentinel lymph nodes
were positive, 4 were positive in pelvic lymph nodes and 1
was negative. Sensitivity and specificity of sentinel lymph
node frozen biopsy were 95.2% (20/21) and 80% (4/5), re-
spectively. The negative predictive value of the technique was
95.2% (20/21) (Table 2). 
DISCUSSION
Sentinel lymph node biopsy in cervical cancer is a promis-
ing surgical technique to confirm nodal status and minimize
postoperative morbidity (5, 9, 12). There are many different
ideas concerning the site of injection of the isosulfan blue dye
and radionuclides, the dose of radioactivity used, the inter-
val between dye injection or lymphoscintigram and sentinel
node frozen biopsy (13-15). Isosulfan blue dye is used for dye-
guided sentinel lymph node biopsy in western countries for
visual detection. According to the initial experience of only
dye-guided sentinel node biopsy, the identification rates of
sentinel lymph nodes ranged between 66% and 82% (12).
Radionuclides for lymphatic mapping should be a few hun-
dred nanometers in size, to permeate the lymphatic vessels
and remain in the sentinel lymph nodes. However, techne-
tium-99m HAS is too small (≤5 nm) to be retained in the
sentinel lymph nodes and technetium-99m TC is too big
(≥500 nm) to migrate through the lymphatic vessels com-
pared with technetium-99m colloid albumin (16). These fac-
tors contributed to low success rate of sentinel node biopsy
with the hand-held gamma probe detector. As for the rela-
tive contribution of each method to the detection of the sen-
tinel node, it should be underlined that the detection rate
was increased by means of combining isosulfan blue dye and
technetium-99m colloid albumin. Hence, whenever it is af-
fordable, isosulfan blue dye in combination with technetium-
99m colloid albumin should be used for the lymphatic map-
ping. The combination of isosulfan blue dye and technetium-
99m colloid albumin can improve the rate of identification
of sentinel lymph nodes up to 100%, and seems to be the
best way to accurately detect sentinel lymph nodes. If sen-
tinel lymph nodes are histologically negative by immediate
frozen section examination, extensive pelvic lymph nodes
dissection can be omitted. However, it may be difficult to
detect micrometastasis of cancer cells by the frozen section
of sentinel lymph nodes. To compensate for this false nega-
tives, it will be helpful to examine multiple sections of sen-
tinel lymph nodes especially with immunohistochemical
staining. In conclusion, sentinel node frozen biopsy with iso-
sulfan blue dye and radionuclide was found to be the best way
to identify sentinel lymph nodes in early stage cervical cancer.
The acceptable false-negative rate remains unclear, but sen-
tinel node biopsy in a multicenter validation study will prove
feasible for predicting pelvic lymph nodes metastases. Our
findings confirm that the detection rate of the sentinel node
(49 of 53, 94%), the overall accuracy (48 of 49, 97%) and
false negative rate (1 of 21, 4.76%) are satisfactory for clini-
cal application. This prospective study provides evidence for
the necessity of coupling lymphoscintigraphy and isosulfan
blue dye and hand held gamma probe detector in order to
enhance the identification rate of sentinel lymph node. Sen-
tinel lymph node biopsy is less invasive than complete pelvic
lymph nodes dissection and lowers both postoperative mor-
bidity and cost. It is expected that sentinel node frozen biopsy
in early stage cervical cancer will be performed as a standard
practice for less extensive pelvic lymph nodes dissection in
the near future.
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